These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31831570)

  • 1.
    Dalmau J; Dalakas MC; Kolson DL; Paul F; Zamvil SS
    Neurol Neuroimmunol Neuroinflamm; 2020 Jan; 7(1):. PubMed ID: 31831570
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune-related adverse events of checkpoint inhibitors.
    Nat Rev Dis Primers; 2020 May; 6(1):39. PubMed ID: 32382085
    [No Abstract]   [Full Text] [Related]  

  • 3. Guidelines for the use of immunoglobulin therapy for primary immune deficiency and solid organ transplantation.
    Nahirniak S; Hume HA
    Transfus Med Rev; 2010 Jan; 24 Suppl 1():S1-6. PubMed ID: 19962578
    [No Abstract]   [Full Text] [Related]  

  • 4. Epidermolysis bullosa aquisita following immune-checkpoint inhibitor treatment for metastatic melanoma.
    O'Connor J; Zhang S; Galante JR; Mee J; Semkova K; Parkar R; Groves R
    Clin Exp Dermatol; 2022 Jun; 47(6):1198-1199. PubMed ID: 35244234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unusual flaccid blistering with mucosal involvement upon immune checkpoint inhibition.
    Niebel D; Brägelmann C; Wenzel J; Bieber T
    J Dtsch Dermatol Ges; 2020 Feb; 18(2):149-152. PubMed ID: 31596533
    [No Abstract]   [Full Text] [Related]  

  • 6. Subclinical Myocarditis After Combination Immune Checkpoint Inhibitor Therapy.
    Giblin GT; Dennehy C; Featherstone H; Clarke R; Murphy L; Timlin D; O'Keane C; Mulligan N; Kelly CM; Joyce E
    Circ Heart Fail; 2021 Feb; 14(2):e007524. PubMed ID: 33478241
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune-related adverse events of checkpoint inhibitors.
    Ramos-Casals M; Brahmer JR; Callahan MK; Flores-Chávez A; Keegan N; Khamashta MA; Lambotte O; Mariette X; Prat A; Suárez-Almazor ME
    Nat Rev Dis Primers; 2020 May; 6(1):38. PubMed ID: 32382051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune-related cutaneous adverse events: A new opportunity for allergists and clinical immunologists.
    Leung DYM
    Ann Allergy Asthma Immunol; 2021 Jun; 126(6):607. PubMed ID: 34049668
    [No Abstract]   [Full Text] [Related]  

  • 9. Recurrence of Immune-Related Adverse Events After Immune Checkpoint Inhibitor Rechallenge.
    Liu J; Yu J; Meng X
    JAMA Oncol; 2020 Nov; 6(11):1813-1814. PubMed ID: 32970130
    [No Abstract]   [Full Text] [Related]  

  • 10. Recurrence of Immune-Related Adverse Events After Immune Checkpoint Inhibitor Rechallenge.
    Zheng SY; Duan H; Cui HJ
    JAMA Oncol; 2020 Nov; 6(11):1813. PubMed ID: 32970125
    [No Abstract]   [Full Text] [Related]  

  • 11. Recurrence of Immune-Related Adverse Events After Immune Checkpoint Inhibitor Rechallenge-Reply.
    Dolladille C; Da-Silva A; Alexandre J
    JAMA Oncol; 2020 Nov; 6(11):1814-1815. PubMed ID: 32970107
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunotherapy Recall: Chemoradiation-Induced Reactivation of Immune Checkpoint Inhibitor Nephritis.
    Weng J; Ajani JA; Murphy MB; Badgwell BD; Tchakarov AS; Mamlouk O; Das P
    JCO Precis Oncol; 2022 Aug; 6():e2200049. PubMed ID: 35952321
    [No Abstract]   [Full Text] [Related]  

  • 13. Adverse and unconventional reactions related to immune checkpoint inhibitor therapy for cancer.
    Li N; Wang G; Hou X; Tai R; Huang S; He Z; Lei L; Xu S; Yang S
    Int Immunopharmacol; 2022 Jul; 108():108803. PubMed ID: 35569432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango?
    Sponaas AM; Waage A; Vandsemb EN; Misund K; Børset M; Sundan A; Slørdahl TS; Standal T
    Front Immunol; 2021; 12():636375. PubMed ID: 33679794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune checkpoint inhibitor endocrinopathies and the role of advanced practice providers in the management of immune-mediated toxicities.
    Cooksley T; Girotra M; Ginex P; Gordon RA; Anderson R; Blidner A; Choi J; Dougan M; Glezerman I; Gupta D; Johnson D; Shannon VR; Suarez-Almazor M; Rapoport BL
    Support Care Cancer; 2020 Dec; 28(12):6175-6181. PubMed ID: 32856213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-mediated cardiovascular, rheumatic, and renal toxicities from checkpoint inhibitors.
    Suarez-Almazor ME; Pundole X; Abdel-Wahab N; Johnson DB; Gupta D; Glezerman I; Cooksley T; Anderson R; Blidner A; Choi J; Dougan M; Ginex P; Girotra M; Shannon VR; Rapoport BL
    Support Care Cancer; 2020 Dec; 28(12):6159-6173. PubMed ID: 32856212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant medications and immune checkpoint inhibitor therapy for cancer: causation or association?
    Hussain N; Naeem M; Pinato DJ
    Hum Vaccin Immunother; 2021 Jan; 17(1):55-61. PubMed ID: 32574106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ["Immune checkpoint inhibitors in oncology"].
    Daëron M; Vivier É
    Rev Prat; 2021 Apr; 71(4):374-379. PubMed ID: 34161001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors.
    Kostine M; Finckh A; Bingham CO; Visser K; Leipe J; Schulze-Koops H; Choy EH; Benesova K; Radstake TRDJ; Cope AP; Lambotte O; Gottenberg JE; Allenbach Y; Visser M; Rusthoven C; Thomasen L; Jamal S; Marabelle A; Larkin J; Haanen JBAG; Calabrese LH; Mariette X; Schaeverbeke T
    Ann Rheum Dis; 2021 Jan; 80(1):36-48. PubMed ID: 32327425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing toxicities associated with immune checkpoint inhibitors.
    Park JJ; Arafath S; Kumar ST; Sharma R; Dixit D
    JAAPA; 2021 Jun; 34(6):32-39. PubMed ID: 34031312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.